Dr. Cuenca completed his medical school, graduate school, and residency at the University of Florida in Gainesville, Fl. During his research hiatus in residency, he obtained a PhD examining the role of innate immunity and toll-like receptor signaling in neonatal sepsis. He then went on to complete a fellowship in Pediatric Surgery at Boston Children’s Hospital. Due to his interest in pediatric hepatobiliary disease and transplant medicine, he went on to complete a fellowship in Transplant Surgery at Massachusetts General Hospital. He is clinically interested in pediatric hepatobiliary and pancreatic disease, solid organ transplantation, mid-aortic vascular disease, and other general surgical conditions of children. His research efforts are focused on examining the role of innate immunity in allograft tolerance, as well as novel efforts to expand the utility of normothermic machine perfusion for use in solid organ transplantation.
Publications
Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation. View Abstract
Pediatric Organ Donation and Transplantation: Across the Care Continuum. View Abstract
Intragraft B cell differentiation during the development of tolerance to kidney allografts is associated with a regulatory B cell signature revealed by single cell transcriptomics. View Abstract
Adjuvant conditioning induces an immunosuppressive milieu that delays alloislet rejection through the expansion of myeloid-derived suppressor cells. View Abstract
Innate immune cellular therapeutics in transplantation. View Abstract
Outcomes of internal biliary diversion using cholecystocolostomy for patients with severe Alagille syndrome. View Abstract
Organ allocation in pediatric abdominal transplant. View Abstract
Functional side-to-side splenorenal shunts to treat extrahepatic portal vein thrombosis in children. View Abstract
Triple gallbladder with heterotopic gastric mucosa: a case report. View Abstract
Prenatal diagnosis of rapidly enlarging choledochal cyst with gastric outlet obstruction. View Abstract
Midaortic syndrome and renovascular hypertension. View Abstract
Short Bowel Syndrome and Kidney Transplantation: Challenges, Outcomes, and the Use of Teduglutide. View Abstract
Resolution of a High Grade and Metastatic BK Polyomavirus-Associated Urothelial Cell Carcinoma Following Radical Allograft Nephroureterectomy and Immune Checkpoint Treatment: A Case Report. View Abstract
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. View Abstract
Pediatric liver transplant following near catastrophic head bleed: Lessons learned. View Abstract
Giant Gastroschisis with Complete Liver Herniation: A Case Report of Two Patients. View Abstract
Emerging implications of nanotechnology on cancer diagnostics and therapeutics. View Abstract
In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity. View Abstract
Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance. View Abstract
Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. View Abstract
A critical role for Stat3 signaling in immune tolerance. View Abstract
Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. View Abstract
Pancreas transplant graft evaluation using the MIBI scan--a useful tool. View Abstract
Pancreaticojejunostomy versus controlled pancreaticocutaneous fistula in pancreaticoduodenectomy for periampullary carcinoma. View Abstract